Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler H P
Division of Hematology, Keio University School of Medicine, Tokyo, Japan.
Blood. 1993 Dec 15;82(12):3592-9.
Retinoic acid modulates proliferation and differentiation of a wide variety of normal and leukemic cells through two distinct families of transcriptional factors: the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). A stereoisomer of retinoic acid, 9-cis-retinoic acid, is a high-affinity ligand for RXR and binds efficiently to RAR. In contrast, all-trans-retinoic acid interacts 40-fold less efficiently with RXR as compared with RAR. To clarify the biologic role of retinoic acid compounds (all-trans,- 9-cis-, and 13-cis-retinoic acid) in hematopoietic cells, we studied their effects on clonal growth, differentiation, and expression of RAR-alpha and RXR-alpha genes in HL-60 cells. At very low concentrations (10(-15) to 10(-12) mmol/L), each retinoid enhanced clonal growth of HL-60 cells. These concentrations of the retinoids had no capacity to induce differentiation of leukemic cells as measured by ability either to reduce nitroblue tetrazolium and to express CD11b antigens, suggesting that retinoids at very low concentrations may stimulate proliferation of leukemic cells rather than induce their differentiation. These findings may help explain why patients with acute promyelocytic leukemia may relapse while receiving retinoic acids. With continuous therapy, retinoids are metabolized rapidly with increased urinary excretion, lowering their plasma levels to a range that may stimulate proliferation without inducing differentiation of leukemic cells. In contrast, we found that at higher concentrations (> or = 10(-11) mmol/L) each retinoid inhibited clonal growth, reduced c-myc RNA levels, and induced differentiation of HL-60 cells. 9-cis-retinoic acid was a slightly more potent inducer of differentiation than all-trans-retinoic acid; the mechanism for this increased potency and its clinical potential requires additional studies. Steady-state levels of RAR-alpha mRNA in HL-60 cells were not affected by either 9-cis- and all-trans-retinoic acid. In contrast, 9-cis-retinoic acid, but not all-trans-retinoic acid, reduced RXR-alpha mRNA accumulation in a dose-dependent manner.
视黄酸通过两类不同的转录因子家族,即视黄酸受体(RARs)和类视黄醇X受体(RXRs),调节多种正常细胞和白血病细胞的增殖与分化。视黄酸的一种立体异构体9-顺式视黄酸,是RXR的高亲和力配体,能有效地与RAR结合。相比之下,全反式视黄酸与RXR相互作用的效率比与RAR相互作用的效率低40倍。为了阐明视黄酸化合物(全反式、9-顺式和13-顺式视黄酸)在造血细胞中的生物学作用,我们研究了它们对HL-60细胞克隆生长、分化以及RAR-α和RXR-α基因表达的影响。在极低浓度(10^(-15)至10^(-12) mmol/L)时,每种类视黄醇都能增强HL-60细胞的克隆生长。通过检测还原硝基蓝四氮唑的能力和表达CD11b抗原的能力来衡量,这些浓度的类视黄醇没有诱导白血病细胞分化的能力,这表明极低浓度的类视黄醇可能刺激白血病细胞增殖而非诱导其分化。这些发现可能有助于解释为什么急性早幼粒细胞白血病患者在接受视黄酸治疗时可能会复发。随着持续治疗,类视黄醇会迅速代谢,尿排泄增加,使其血浆水平降至可能刺激增殖而不诱导白血病细胞分化的范围。相比之下,我们发现,在较高浓度(≥10^(-11) mmol/L)时,每种类视黄醇都会抑制克隆生长,降低c-myc RNA水平,并诱导HL-60细胞分化。9-顺式视黄酸诱导分化的能力略强于全反式视黄酸;这种增强效力的机制及其临床潜力需要进一步研究。HL-60细胞中RAR-α mRNA的稳态水平不受9-顺式和全反式视黄酸的影响。相比之下,9-顺式视黄酸而非全反式视黄酸以剂量依赖的方式降低RXR-α mRNA的积累。